MicroRNA Array Analysis Finds Elevated Serum miR-1290 Accurately Distinguishes Patients with Low-Stage Pancreatic Cancer from Healthy and Disease Controls

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Clinical Cancer Research

• Publication date

  2013-05-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-12-3092PMID 23697990PMCID PMC3707520
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer.

  2013cited by this paper
• Pancreatic cancer.

  2013cited by this paper
• Mutant GNAS detected in duodenal collections of secretin-stimulated pancreatic juice indicates the presence or emergence of pancreatic cysts

  2012cited by this paper
• The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer

  2012cited by this paper
• Cancer statistics, 2012

  2012cited by this paper
• Diagnosis of Pancreatic Ductal Adenocarcinoma and Chronic Pancreatitis by Measurement of microRNA Abundance in Blood and Tissue

  2012cited by this paper
• Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer.

  2012cited by this paper
• miRNA Biomarkers in Cyst Fluid Augment the Diagnosis and Management of Pancreatic Cysts

  2012cited by this paper
• International Cancer of the Pancreas Screening (CAPS) Consortium summit on the management of patients with increased risk for familial pancreatic cancer

  2012cited by this paper
• Presence of somatic mutations in most early-stage pancreatic intraepithelial neoplasia.

  2012cited by this paper
• Frequent detection of pancreatic lesions in asymptomatic high-risk individuals.

  2012cited by this paper
• Global microRNA expression profiling of microdissected tissues identifies miR‐135b as a novel biomarker for pancreatic ductal adenocarcinoma

  2012cited by this paper
• Breast cancer risk-associated SNPs modulate the affinity of chromatin for FOXA1 and alter gene expression

  2012cited by this paper
• Combination of plasma microRNAs with serum CA19‐9 for early detection of pancreatic cancer

  2012cited by this paper
• Feasibility and Yield of Screening in Relatives From Familial Pancreatic Cancer Families

  2011cited by this paper
• Recurrent GNAS Mutations Define an Unexpected Pathway for Pancreatic Cyst Development

  2011cited by this paper
• Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas

  2011cited by this paper
• Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer

  2011cited by this paper
• Serum Biomarker Panels for the Detection of Pancreatic Cancer

  2011cited by this paper
• Pancreatic cancer

  2011cited by this paper
• MicroRNA Alterations of Pancreatic Intraepithelial Neoplasias

  2011influential reference
• Loss of FOXA1/2 is essential for the epithelial-to-mesenchymal transition in pancreatic cancer.

  2010cited by this paper
• Pancreatic cancers epigenetically silence SIP1 and hypomethylate and overexpress miR-200a/200b in association with elevated circulating miR-200a and miR-200b levels.

  2010cited by this paper
• Pancreatic Cancer Screening in a Prospective Cohort of High-Risk Patients: A Comprehensive Strategy of Imaging and Genetics

  2010cited by this paper
• miR-146a suppresses invasion of pancreatic cancer cells.

  2010cited by this paper
• Detection of Early-Stage Pancreatic Adenocarcinoma

  2010cited by this paper
• MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma.

  2010cited by this paper
• Aberrant MicroRNA-155 Expression Is an Early Event in the Multistep Progression of Pancreatic Adenocarcinoma

  2010cited by this paper
• Rapid in situ codetection of noncoding RNAs and proteins in cells and formalin-fixed paraffin-embedded tissue sections without protease treatment

  2010cited by this paper
• Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer.

  2010cited by this paper
• Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer

  2009cited by this paper
• MicroRNAs in Plasma of Pancreatic Ductal Adenocarcinoma Patients as Novel Blood-Based Biomarkers of Disease

  2009cited by this paper
• A resource for analysis of microRNA expression and function in pancreatic ductal adenocarcinoma cells

  2009cited by this paper
• The Yield of First-Time Endoscopic Ultrasonography in Screening Individuals at a High Risk of Developing Pancreatic Cancer

  2009cited by this paper
• Imaging individual microRNAs in single mammalian cells in situ

  2009cited by this paper
• A Compendium of Potential Biomarkers of Pancreatic Cancer

  2009cited by this paper
• Circulating microRNAs as stable blood-based markers for cancer detection

  2008cited by this paper
• Analysis of microRNAs in pancreatic fine-needle aspirates can classify benign and malignant tissues.

  2008cited by this paper
• High-throughput stem-loop RT-qPCR miRNA expression profiling using minute amounts of input RNA

  2008cited by this paper
• ANGIOPOIETIN-2, A REGULATOR OF VASCULAR PERMEABILITY IN INFLAMMATION IS ELEVATED IN SEVERE ACUTE PANCREATITIS AND IS ASSOCIATED WITH SYSTEMIC ORGAN FAILURE

  2008cited by this paper
• MicroRNA-21 is Overexpressed in Pancreatic Cancer and a Potential Predictor of Survival

  2008cited by this paper
• MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma

  2007cited by this paper
• MicroRNA expression patterns to differentiate pancreatic adenocarcinoma from normal pancreas and chronic pancreatitis.

  2007cited by this paper
• Screening for early pancreatic neoplasia in high-risk individuals: a prospective controlled study.

  2006cited by this paper
• 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience

  2006cited by this paper
• DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease.

  2006cited by this paper
• Serum Markers in Patients with Resectable Pancreatic Adenocarcinoma: Macrophage Inhibitory Cytokine 1 versus CA19-9

  2006cited by this paper
• Screening for pancreatic neoplasia in high-risk individuals: an EUS-based approach.

  2004cited by this paper
• Early Diagnosis and Treatment of Pancreatic Dysplasia in Patients with a Family History of Pancreatic Cancer

  1999cited by this paper
• Controlling the false discovery rate: a practical and powerful approach to multiple testing

  1995cited by this paper
• Cancer statistics

  1989cited by this paper
• Open Access Research

  year unknowncited by this paper

• Nuclear miR-3920 expression in hepatocellular carcinoma is associated with stemness marker expression and poorer prognosis.

  2026cites this paper
• Investigation of MicroRNAs as predictors of radioligand therapy response in gastroenteropancreatic neuroendocrine tumours.

  2026cites this paper
• Extracellular vesicles in burn injury: roles, mechanisms, and applications

  2025cites this paper
• Blood-based biomarkers in pancreatic ductal adenocarcinoma: developments over the last decade and what holds for the future- a review

  2025cites this paper
• Non-Coding RNA Signatures in Breast and Pancreatic Cancer: from Molecular Drivers To Diagnostic Tools

  2025cites this paper
• Regulatory roles of non-coding and exosomal RNAs in colorectal cancer: spotlight on angiogenesis

  2025cites this paper
• Recent research advances in interleukin, microRNA and neuroendocrine tumor biomarkers (Review)

  2025cites this paper
• Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications

  2025cites this paper
• Analysis of Methylation of Tumor-suppressive miRNAs and KRAS/TP53 Mutations in Pancreatic Juice

  2024cites this paper
• Development of a Serum-Based MicroRNA Signature for Early Detection of Pancreatic Cancer: A Multicenter Cohort Study

  2024cites this paper
• Multi-omic markers of Intraductal Papillary Mucinous Neoplasms progression into pancreatic cancer.

  2024cites this paper
• Functionalized Nanomaterials In Pancreatic Cancer Theranostics And Molecular Imaging

  2024cites this paper
• Circulating non-coding RNA biomarkers of endocrine tumours

  2024influential citation
• MicroRNAs as Promising Therapeutic Agents Against Prostate Cancer Resistant to Castration—Where Are We Now?

  2024cites this paper
• Integrated Analysis of Serum and Tissue microRNA Transcriptome for Biomarker Discovery in Gastric Cancer

  2024cites this paper
• miRNA Expression Profiling in G1 and G2 Pancreatic Neuroendocrine Tumors

  2024cites this paper
• Evaluation of Mir-1290 as a Possible Diagnostic Factor in the Serum of Oral Squamous Cell Carcinoma Patients with Qualitative Real-Time Polymerase Chain Reaction

  2024cites this paper
• Gastroenteropancreatic neuroendocrine tumors: Epigenetic landscape and clinical implications.

  2024cites this paper
• Biochemical Markers for Neuroendocrine Tumors: Traditional Circulating Markers and Recent Development—A Comprehensive Review

  2024cites this paper
• Using microRNAs Networks to Understand Pancreatic Cancer—A Literature Review

  2024cites this paper
• Circulating microRNAs in association with pancreatic cancer risk within 5 years

  2024cites this paper
• Oncogenic miR‐1825 promotes head and neck carcinogenesis via targeting FREM1

  2023cites this paper
• Novel microRNAs modulating ecto-5′-nucleotidase expression

  2023cites this paper
• A circulating microRNA panel as a novel dynamic monitor for oral squamous cell carcinoma

  2023cites this paper
• Evolving utility of exosomes in pancreatic cancer management

  2023cites this paper
• Application of mesenchymal stem cell exosomes in the treatment of skin wounds

  2023cites this paper
• An Overview of Circulating Biomarkers in Neuroendocrine Neoplasms: A Clinical Guide

  2023cites this paper
• The perfect trio to decrease mortality in pancreatic cancers: Molecular marker screening tests with biosensors in precancerous lesions

  2023influential citation
• A Comprehensive Review of the Potential Role of Liquid Biopsy as a Diagnostic, Prognostic, and Predictive Biomarker in Pancreatic Ductal Adenocarcinoma

  2023cites this paper
• Correlations of miR-1290 and miR-191-5p with laboratory parameters as a useful test to differentiate pancreatic cancer from chronic pancreatitis: preliminary study

  2023cites this paper
• CRISPR-Cas12a powered hybrid nanoparticle for extracellular vesicle aggregation and in-situ microRNA detection.

  2023cites this paper
• An Insight into miR-1290: An Oncogenic miRNA with Diagnostic Potential

  2022cites this paper
• Pancreatic Neuroendocrine Neoplasms: Updates on Genomic Changes in Inherited Tumour Syndromes and Sporadic Tumours Based on WHO Classification.

  2022cites this paper
• A pilot study to troubleshoot quality control metrics when assessing circulating miRNA expression data reproducibility across study sites

  2022cites this paper
• Circulating Neuroendocrine Tumor Biomarkers: Past, Present and Future

  2022cites this paper
• miR-1290 modulates the radioresistance of triple-negative breast cancer by targeting NLRP3-mediated pyroptosis

  2022cites this paper
• Molecular biology of pancreatic neuroendocrine tumors: From mechanism to translation

  2022cites this paper
• Ho2O3-TiO2 Nanobelts Electrode for Highly Selective and Sensitive Detection of Cancer miRNAs

  2022cites this paper
• MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions

  2022cites this paper
• Phaseolus vulgaris Erythroagglutinin (PHA-E)-Positive Ceruloplasmin Acts as a Potential Biomarker in Pancreatic Cancer Diagnosis

  2022cites this paper
• RNA‐sequencing for transcriptional profiling of whole blood in early stage and metastatic pancreatic cancer patients

  2022cites this paper
• Pancreatic Incidentaloma

  2022cites this paper
• Methylation of Tumor Suppressive miRNAs in Plasma from Patients With Pancreaticobiliary Diseases.

  2022cites this paper
• miR-484: A Potential Biomarker in Health and Disease

  2022cites this paper
• OmicSelector: automatic feature selection and deep learning modeling for omic experiments

  2022cites this paper
• Biomarker Landscape in Neuroendocrine Tumors With High-Grade Features: Current Knowledge and Future Perspective

  2022cites this paper
• Diagnosis of Pancreatic Cancer Using miRNA30e Biosensor

  2022cites this paper
• Circulating Exosomal miR-1290 for Diagnosis of Epithelial Ovarian Cancer

  2022cites this paper
• A Liquid Biopsy Signature for the Detection of Patients with Early-Onset Colorectal Cancer.

  2022cites this paper
• Circulating MicroRNAs as Noninvasive Diagnostic and Prognostic Biomarkers in Pancreatic Cancer: A Review

  2022cites this paper
• The Role of miRNA in the Pathophysiology of Neuroendocrine Tumors

  2021cites this paper
• Pancreatic Cancer Small Extracellular Vesicles (Exosomes): A Tale of Short- and Long-Distance Communication

  2021cites this paper
• Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?

  2021cites this paper
• Early screening and diagnosis strategies of pancreatic cancer: a comprehensive review

  2021cites this paper
• Recent Advances in Pancreatic Cancer: Novel Prognostic Biomarkers and Targeted Therapy—A Review of the Literature

  2021cites this paper
• Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy

  2021cites this paper
• Blood biomarkers for differential diagnosis and early detection of pancreatic cancer.

  2021cites this paper
• Clinical Usefulness of Biological Markers in Pancreatic Cancer

  2021cites this paper
• Current State of “Omics” Biomarkers in Pancreatic Cancer

  2021influential citation
• Molecular Approaches Using Body Fluid for the Early Detection of Pancreatic Cancer

  2021cites this paper
• Non-Invasive Biomarkers for Earlier Detection of Pancreatic Cancer—A Comprehensive Review

  2021cites this paper
• The Role of microRNA in Pancreatic Cancer

  2021cites this paper
• Comparison of Characteristics and Survival Rates of Resectable Pancreatic Ductal Adenocarcinoma according to Tumor Location

  2021cites this paper
• The potential role of miR‐1290 in cancer progression, diagnosis, prognosis, and treatment: An oncomiR or onco‐suppressor microRNA?

  2021influential citation
• Multi-Omic Biomarkers as Potential Tools for the Characterisation of Pancreatic Cystic Lesions and Cancer: Innovative Patient Data Integration

  2021cites this paper
• Carbohydrate antigen 125 supplements carbohydrate antigen 19-9 for the prediction of invasive intraductal papillary mucinous neoplasms of the pancreas

  2021cites this paper
• Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1

  2021cites this paper
• A Review on the Role of miR-1290 in Cell Proliferation, Apoptosis and Invasion

  2021cites this paper
• miR-1290 contributes to oncogenesis and angiogenesis via targeting of THBS1, DKK3 and, SCAI

  2021cites this paper
• A microRNA-based signature predicts local-regional failure and overall survival after pancreatic cancer resection

  2020cites this paper
• Prediction of MiR-21-5p in Promoting the Development of Lung Adenocarcinoma via PDZD2 Regulation

  2020cites this paper
• Circulating MiR-1290 as a potential diagnostic and disease monitoring biomarker of human gastrointestinal tumors

  2020cites this paper
• Enhancement of resistance to chemo-radiation by hsa-miR-1290 expression in glioblastoma cells.

  2020cites this paper
• Novel Circulating miRNA Signatures for Early Detection of Pancreatic Neoplasia

  2020cites this paper
• Prognostic value of microRNAs in pancreatic cancer: a meta-analysis

  2020influential citation
• Clinical Significance of Circulating miR-1273g-3p and miR-122-5p in Pancreatic Cancer

  2020cites this paper
• Electrochemical sensing of pancreatic cancer miR-1290 based on yeast-templated mesoporous TiO2 modified electrodes.

  2020cites this paper
• Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.

  2020cites this paper
• Serum miR-1290 and miR-1246 as Potential Diagnostic Biomarkers of Human Pancreatic Cancer

  2020influential citation
• Effect of cardiac rehabilitation on circulating microRNA expression in heart failure: a preliminary study

  2020cites this paper
• MiRNAs directly targeting the key intermediates of biological pathways in pancreatic cancer.

  2020cites this paper
• Implementing biological markers as a tool to guide clinical care of patients with pancreatic cancer

  2020cites this paper
• Serum levels of miR-223 but not miR-21 are decreased in patients with neuroendocrine tumors

  2020cites this paper
• MicroRNAs as Biomarkers of High-risk Pancreatic Cysts: A Possible Holy Grail for the Early Detection of Pancreatic Cancer

  2020cites this paper
• Non-coding RNA biomarkers in pancreatic ductal adenocarcinoma.

  2020cites this paper
• Blood-Based Circulating RNAs as Preventive, Diagnostic, Prognostic and Druggable Biomarkers for Pancreatic Ductal Adenocarcinoma

  2020cites this paper
• Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma

  2020cites this paper
• Comparison of microRNA Expression Profile in Chronic Myeloid Leukemia Patients Newly Diagnosed and Treated by Allogeneic Hematopoietic Stem Cell Transplantation

  2020cites this paper
• Extracellular Vesicles (EVs) and Pancreatic Cancer: From the Role of EVs to the Interference with EV-Mediated Reciprocal Communication

  2020cites this paper
• Prostate cancer early diagnosis: circulating microRNA pairs potentially beyond single microRNAs upon 1231 serum samples

  2020cites this paper
• Altered miRNAs Expression Correlates With Gastroenteropancreatic Neuroendocrine Tumors Grades

  2020cites this paper
• Circulating miRNA Increases the Diagnostic Accuracy of Chromogranin A in Metastatic Pancreatic Neuroendocrine Tumors

  2020cites this paper
• Clinical relevance and functional significance of cell-free microRNA-1260b expression profiles in infiltrative myxofibrosarcoma

  2020cites this paper
• Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review

  2019cites this paper
• Molecular Diagnostic in Prostate Cancer

  2019cites this paper
• Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review

  2019cites this paper
• Cell-free microRNAs as Non-invasive Diagnostic and Prognostic Bio- markers in Pancreatic Cancer

  2019influential citation
• Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis

  2019cites this paper
• Circulating miRNA-1290 as a potential biomarker for response to chemoradiotherapy and prognosis of patients with advanced oral squamous cell carcinoma: A single-center retrospective study

  2019cites this paper
• Advances in Translational Research and Clinical Care in Pancreatic Cancer: Where Are We Headed?

  2019influential citation